A detailed history of Sawtooth Solutions, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Sawtooth Solutions, LLC holds 3,349 shares of MRNA stock, worth $128,099. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,349
Previous 4,411 24.08%
Holding current value
$128,099
Previous $455,000 26.81%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

SELL
$69.51 - $104.43 $73,819 - $110,904
-1,062 Reduced 24.08%
3,349 $333,000
Q3 2023

Oct 19, 2023

BUY
$96.41 - $126.61 $47,915 - $62,925
497 Added 12.7%
4,411 $455,000
Q2 2023

Jul 26, 2023

SELL
$118.5 - $160.53 $489,286 - $662,828
-4,129 Reduced 51.34%
3,914 $475,000
Q1 2023

Apr 27, 2023

BUY
$135.66 - $197.02 $682,369 - $991,010
5,030 Added 166.94%
8,043 $1.24 Million
Q4 2022

Feb 02, 2023

BUY
$118.38 - $210.04 $51,613 - $91,577
436 Added 16.92%
3,013 $541,000
Q3 2022

Oct 12, 2022

BUY
$118.07 - $194.18 $25,503 - $41,942
216 Added 9.15%
2,577 $305,000
Q2 2022

Jul 19, 2022

SELL
$117.13 - $176.59 $51,537 - $77,699
-440 Reduced 15.71%
2,361 $337,000
Q1 2022

May 20, 2022

SELL
$126.46 - $235.05 $200,439 - $372,554
-1,585 Reduced 36.14%
2,801 $483,000
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $297,630 - $485,696
1,318 Added 42.96%
4,386 $1.11 Million
Q3 2021

Nov 09, 2021

BUY
$221.9 - $484.47 $397,201 - $867,201
1,790 Added 140.06%
3,068 $1.18 Million
Q2 2021

Sep 01, 2021

BUY
$129.91 - $234.98 $166,024 - $300,304
1,278 New
1,278 $300,000
Q3 2020

Nov 04, 2020

SELL
$54.34 - $94.85 $182,310 - $318,221
-3,355 Closed
0 $0
Q2 2020

Aug 06, 2020

BUY
$29.67 - $80.0 $99,542 - $268,400
3,355 New
3,355 $215,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.